Summary & Overview
HCPCS M1181: Grade 2+ Diarrhea and/or Colitis
HCPCS Level II code M1181 identifies grade 2 or above diarrhea and/or grade 2 or above colitis, signifying moderate-to-severe gastrointestinal toxicity that often requires intensified clinical management. Nationally, accurate use of this code supports consistent reporting of adverse events, informs severity-based care pathways, and affects claims processing for services delivered in higher-acuity settings.
Key payers in the discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for M1181, typical sites of service where the code is applied, and the role of the code in service-line reporting. The publication also covers common billing modifiers associated with complex care, expected documentation elements tied to grade 2+ diarrhea or colitis, and how payers commonly handle claims for higher-grade gastrointestinal events.
This summary provides benchmarks and policy-relevant guidance on coding consistency, clarifies clinical triggers for assigning M1181, and highlights administrative considerations for hospitals, emergency departments, and oncology clinics managing these adverse events. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code M1181 denotes grade 2 or above diarrhea and/or grade 2 or above colitis. This code is used to identify moderate to severe gastrointestinal toxicity events characterized by clinically significant diarrhea or colitis that meet at least grade 2 severity criteria.
-
Service type: Medical evaluation and management of moderate-to-severe gastrointestinal adverse events
-
Typical site of service: Hospital inpatient, emergency department, or oncology infusion clinic where management of higher-grade diarrhea or colitis commonly occurs
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient receiving immune checkpoint inhibitor therapy for metastatic melanoma presents to the oncology clinic with a 5-day history of frequent watery stools (6–8 per day), abdominal cramping, and moderate urgency. Vital signs show low-grade fever and mild tachycardia; labs reveal mild leukocytosis and mild dehydration. The oncology advanced practice provider assesses severity as Grade 2 diarrhea/colitis per Common Terminology Criteria for Adverse Events (CTCAE) — increased stool frequency over baseline, moderate symptoms limiting instrumental activities of daily living. Management workflow includes triage by nursing, symptom assessment, stool studies to rule out infectious causes, ordering outpatient intravenous fluids if needed, holding immunotherapy doses, initiating antidiarrheal and anti-inflammatory therapy (e.g., oral corticosteroids), and scheduling close follow-up with oncology. Documentation supports billing for a service defined as care related to Grade 2 or above diarrhea and/or colitis under M1181, with time- and decision-based notes, interventions provided, and any modifiers applied to reflect unusual circumstances (for example, increased procedural complexity or same-day surgery). Typical sites of service include outpatient oncology clinic, infusion center, or emergency department depending on acuity. Common patient scenario variations include steroid-refractory symptoms progressing to hospitalization and specialist gastroenterology consultation for endoscopic evaluation and escalation of immunosuppression.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|